MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 66 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,250 | -2.3% | 25,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $33,000 | +85.9% | 25,000 | 0.0% | 0.00% | – |
| Q1 2023 | $17,750 | -52.7% | 25,000 | -50.0% | 0.00% | -100.0% |
| Q4 2022 | $37,500 | +70.5% | 50,000 | +100.0% | 0.00% | – |
| Q3 2022 | $22,000 | -21.4% | 25,000 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $28,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 2,188,606 | $1,641,455 | 0.95% |
| Monaco Asset Management SAM | 2,049,661 | $1,537,246 | 0.46% |
| Rubric Capital Management LP | 10,366,120 | $7,774,590 | 0.34% |
| Clearline Capital LP | 2,052,709 | $1,539,532 | 0.28% |
| DAFNA Capital Management LLC | 1,096,513 | $822,385 | 0.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,364,438 | $5,523,329 | 0.23% |
| Orbimed Advisors | 10,605,522 | $7,954,142 | 0.15% |
| Octagon Capital Advisors LP | 1,000,000 | $750,000 | 0.12% |
| Rock Springs Capital Management LP | 6,244,897 | $4,683,673 | 0.11% |
| Privium Fund Management (UK) Ltd | 177,200 | $132,900 | 0.10% |